Nahdiya Laila Mufida

Nahdiya Laila Mufida

Auto-generated profile, based on publicly available information

Nahdiya Laila Mufida

School of Life Science and Technology, Institut Teknologi Bandung, Bandung 40132, Indonesia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2026 in HAYATI Journal of Biosciences
Verified
Journal Article
Open access
PDF file
NMNahdiya Laila Mufida
Nahdiya Laila Mufida
ASArum Sinda Santika
Arum Sinda Santika
MAMarissa Angelina
Marissa Angelina
DADian Fitria Agustiyanti
Dian Fitria Agustiyanti
PWPopi Hadi Wisnuwardhani
Popi Hadi Wisnuwardhani
AFAzzania Fibriani
Azzania Fibriani
The chemical crosslinking method has been effective in previous studies for interaction-based drug screening. Although CDs have been widely explored as antiviral candidates, studies that use chemical crosslinking to select effective CDs against SARS-CoV-2 remain limited. To address this gap, this study uses chemical crosslinking to test CDs as antiviral compounds. The objective of this study is to screen and determine the potential of CDs as candidate antiviral compounds for inhibiting the dimerization of the SARS-CoV-2 N-CTD protein using a chemical crosslinking method. Recombinant SARS-CoV-2 N-CTD protein was expressed, purified, and precipitated for compound testing with chemical crosslinking. The concentration ranges used in the dimerization inhibition testing were 0-2,000 ppm (pyrrolic-N CDs) and 0-6,000 ppm (pyridinic-N, graphitic-N, and nuciferine-derived CDs). The study’s results show that CDs have the potential to inhibit dimerization of the SARS-CoV-2 N-CTD protein. Among the four compounds tested, pyrrolic-N CDs showed the best inhibitory potential, as they inhibited dimerization at the lowest concentration (2,000 ppm), had the smallest percentage of dimer bands to total protein, and achieved the highest dimerization inhibition efficiency. However, further research, including in vitro and in vivo tests, is needed to comprehensively evaluate the potential of pyrrolic-N CDs.